Related news and resources
Industry perspectives on implementation of Quality Overall Summary-Product Dossier (QOS-PD) and Quality Information Summary (QIS) for innovative medicinal products
In view of a growing complexity of product lifecycle management, industry puts forward perspectives to support the harmonization of regulatory requirements. These are intended to facilitate efficient regulatory review and approval to support timely implementation of changes and product improvements, leading to more resilient supply chains.
The socio-economic value of adult Immunization programs (OHE)
The study “The Socio-Economic Value of Adult Immunization” by the Office of Health Economics (OHE) synthesizes existing evidence for the broad, socio-economic value of adult immunization programs. It focuses on influenza, pneumococcal, herpes zoster (HZ), and respiratory syncytial virus (RSV) programs in 10 countries where the vaccines have been publicly recommended (Australia, Brazil, France, Germany,...
Innovative pharmaceutical industry statement on COP28 Declaration on Climate and Health
On 3 December, ABPI, EFPIA, Farmindustria, IFPMA, IMC, JPMA, Leem, PhRMA, and vfa issued a joint statement on climate and health at the 2023 UN Conference on Climate Change, referred to as COP28. The COP28 is taking place 30 November-12 December in Dubai, UAE.